Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03039192
Brief Title: A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide (Aspire I)

First Submitted : January 31, 2017
First Submitted that Met QC Criteria : January 31, 2017
First Posted : February 1, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : February 8, 2019
Last Update Posted : February 11, 2019